Caxton Associates LLP Takes Position in Azenta, Inc. $AZTA

Key Points

• Caxton Associates LLP has taken a new position in Azenta, Inc. by purchasing 38,891 shares valued at approximately $1,347,000, representing 0.08% of the company’s stock.
• Institutional ownership of Azenta is notably high, with 99.08% of the company's stock held by institutional investors and hedge funds, contributing to significant ownership changes in the fourth quarter by several firms.
• Research analysts have a consensus rating of "Hold" for Azenta, with an average price target of $35.75, highlighting mixed sentiment in the market despite a recent earnings report that beat expectations.

Caxton Associates LLP bought a new stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 38,891 shares of the company's stock, valued at approximately $1,347,000. Caxton Associates LLP owned 0.08% of Azenta at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the business. Dynamic Technology Lab Private Ltd acquired a new position in shares of Azenta in the 1st quarter valued at about $505,000. Park West Asset Management LLC increased its holdings in Azenta by 10.6% in the first quarter. Park West Asset Management LLC now owns 331,743 shares of the company's stock worth $11,492,000 after buying an additional 31,743 shares during the last quarter. Millennium Management LLC increased its holdings in Azenta by 214.8% in the first quarter. Millennium Management LLC now owns 340,580 shares of the company's stock worth $11,798,000 after buying an additional 232,405 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new position in Azenta in the first quarter worth approximately $435,000. Finally, Graham Capital Management L.P. acquired a new position in Azenta in the first quarter worth approximately $1,820,000. Institutional investors and hedge funds own 99.08% of the company's stock.

Azenta Stock Up 0.6%

AZTA stock traded up $0.19 during midday trading on Monday, hitting $29.85. 166,289 shares of the company traded hands, compared to its average volume of 740,350. Azenta, Inc. has a twelve month low of $23.91 and a twelve month high of $55.63. The business has a 50 day simple moving average of $31.16 and a 200-day simple moving average of $30.90. The stock has a market capitalization of $1.37 billion, a price-to-earnings ratio of -12.28 and a beta of 1.65.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.13 by $0.06. Azenta had a positive return on equity of 1.35% and a negative net margin of 18.45%.The company had revenue of $143.94 million for the quarter, compared to the consensus estimate of $149.64 million. During the same quarter last year, the company posted $0.14 earnings per share. The company's revenue for the quarter was up .0% compared to the same quarter last year. Equities research analysts forecast that Azenta, Inc. will post 0.53 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on AZTA shares. Evercore ISI set a $33.00 price objective on Azenta and gave the stock an "in-line" rating in a report on Tuesday, August 5th. Stephens started coverage on Azenta in a report on Tuesday, July 22nd. They issued an "equal weight" rating and a $35.00 price objective on the stock. Finally, Raymond James Financial upgraded Azenta from a "market perform" rating to an "outperform" rating and set a $35.00 price objective on the stock in a report on Wednesday, August 6th. Two research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Azenta presently has an average rating of "Hold" and an average price target of $35.75.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.